Corteva, Inc. (CTVA) Earnings
Corteva, Inc. is expected to report next earnings on July 30, 2026 (in NaN days), with a consensus EPS estimate of $2.22. CTVA has beaten EPS estimates in 11 of its last 12 reported quarters (average surprise +11.4% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 6, 2026 | $1.17 | $1.50 | +28.2% | $4.9B | +5.7% |
| Feb 3, 2026 | $0.22 | $0.22 | -1.3% | $3.9B | -7.8% |
| Aug 6, 2025 | $1.89 | $2.20 | +16.4% | $6.5B | +3.0% |
| Feb 5, 2025 | $0.31 | $0.32 | +2.5% | $4.0B | -1.5% |
| Jul 31, 2024 | $1.73 | $1.83 | +5.8% | $6.1B | -0.6% |
| May 1, 2024 | $0.82 | $0.89 | +8.1% | $4.5B | -3.4% |
| Jan 31, 2024 | $0.06 | $0.15 | +155.4% | $3.7B | +2.8% |
| Aug 3, 2023 | $1.58 | $1.60 | +1.3% | $6.0B | +100.9% |
| May 3, 2023 | $0.93 | $1.16 | +24.7% | $4.9B | -26.4% |
| Feb 1, 2023 | $0.06 | $0.16 | +166.7% | $3.8B | +1.0% |
| Nov 3, 2022 | $-0.23 | $-0.12 | +47.8% | $2.8B | +7.2% |
| Aug 4, 2022 | $1.46 | $1.64 | +12.3% | $6.3B | +2.8% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · May 6, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
Charles Victor Magro noted spring planting in the Northern Hemisphere is proceeding well with strong crop acreage supporting seed and crop protection volume demand. Both Seed and CP had double-digit EBITDA gains. David P. Johnson discussed financial results, organic sales growth, cost savings, and reaffirmed full-year guidance. They also provided updates on the separation process, including the new company names, executive leadership teams, and progress on Form 10 filings. Judd O’Connor and Robert King provided details on seed and crop protection operations, including corn and soybean acreage trends, crop protection volume drivers, and biofuels initiatives.
Guidance
Corteva, Inc. continues to expect operating EBITDA in the range of $4 billion to $4.2 billion with margins of 22% to 23%, and operating EPS of $3.45 to $3.70, representing approximately 7% growth at the midpoint. First half performance driven by strong execution in North American seed with overall price mix roughly flat. Second half expected to continue momentum with volume growth in crop protection, particularly in Latin America, and stable demand in seed supported by stable corn acreage in Brazil. Tariffs are trending slightly better than expected, while higher oil prices are a $40 million headwind, and currency is expected to be a tailwind in the second half.
Segment performance
Both Seed and CP delivered healthy double-digit EBITDA gains. Organic sales were up 7% compared to last year, with seed up 9% and crop protection up 4%. Currency was a tailwind to the top line at 4% of sales. Seed price mix was up 3% in the quarter with gains in all regions and seed volumes up 6%. Crop protection price was down 2% driven by competitive market dynamics, primarily in Latin America, but volume was up 6% with gains in every region, including double-digit gains in new products and Spinosyns. Operating EBITDA was up 21% over last year with an operating EBITDA margin of over 29% up 240 basis points.
Risks & headwinds
Back half risks are monitored, including impact of Middle East conflict on oil prices, global crop production and geopolitical uncertainty affecting margins, farmer input costs impacted by higher oil prices, and potential changes in crop acreage and market dynamics that could affect volume and pricing.
Analyst Q&A
Q: Christopher S. Parkinson asked about competitive positioning and optionality;
A: Charles Victor Magro discussed technology, cost productivity, and pipeline.
Q: Vincent Stephen Andrews asked about crop chemicals S&D environment;
A: Charles Victor Magro discussed industry cycle, China export controls, etc.
Q: Joel Jackson asked about Q4 earnings push and 2026 bridge;
A: David P. Johnson and Charles Victor Magro discussed.
Q: Joel Jackson asked about corn-soy volume and free cash flow;
A: Judd O’Connor and David P. Johnson discussed.
Q: Duffy Fischer asked about Latin America acreage and working capital;
A: Judd O’Connor and David P. Johnson discussed.
Q: Joshua Spector asked about crop chem volume acceleration;
A: Robert King discussed.
Q: Analyst asked about Middle East and biofuels;
A: Charles Victor Magro and Judd O’Connor discussed.
Q: Benjamin Theurer asked about capital structure for new businesses;
A: David P. Johnson discussed.
Q: Laurence Alexander asked about spin-off dis-synergies;
A: David P. Johnson discussed.
Q: Arun Viswanathan asked about seed competitive environment;
A: Judd O’Connor discussed.
Q: Patrick David Cunningham asked about CP patented product mix;
A: Robert King discussed